Hormone Therapy and Radiotherapy for Intermediate Risk Prostate Cancer

Seminars in Radiation Oncology ◽

10.1016/j.semradonc.2007.09.002 ◽

2008 ◽

Vol 18 (1) ◽

pp. 7-14 ◽

Author(s):

Irwin Lee ◽

Howard Sandler

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Dose Escalation Impacts Biochemical Outcomes of Inadequate PSA Nadir During Neoadjuvant Hormone Therapy Before Brachytherapy for Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.926 ◽

2013 ◽

Vol 87 (2) ◽

pp. S352-S353

Author(s):

A. Yorozu ◽

S. Saito ◽

K. Toya ◽

K. Yoshida ◽

A. Takahashi ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Dose Escalation ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Download Full-text

Combined Hypofractionated Radiation and Hormone Therapy for the Treatment of Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.09.004 ◽

2008 ◽

Vol 71 (1) ◽

pp. 58-63 ◽

Author(s):

Michael Yassa ◽

Bernard Fortin ◽

Marie-Andrée Fortin ◽

Carole Lambert ◽

Thu Van Nguyen ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Hypofractionated Radiation

Download Full-text

7033 Five-year results of disease control and quality of life analysis of a combined hypofractionated radiation and hormone therapy regimen for intermediate-risk prostate cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71411-9 ◽

2009 ◽

Vol 7 (2) ◽

pp. 416

Author(s):

A. Roux ◽

M. Yassa ◽

C. Lambert ◽

B. Fortin ◽

M. Audet-Lapointe ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Disease Control ◽

Hormone Therapy ◽

Intermediate Risk ◽

Therapy Regimen ◽

Risk Prostate Cancer ◽

Life Analysis ◽

Hypofractionated Radiation

Download Full-text

Five-year Results of Disease Control and Quality of Life Analysis of a Combined Hypofractionated Radiation and Hormone Therapy Regimen for Intermediate-risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.737 ◽

2009 ◽

Vol 75 (3) ◽

pp. S321 ◽

Author(s):

A. Roux ◽

M. Yassa ◽

C. Lambert ◽

B. Fortin ◽

M. Audet-Lapointe ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Disease Control ◽

Hormone Therapy ◽

Intermediate Risk ◽

Therapy Regimen ◽

Risk Prostate Cancer ◽

Life Analysis ◽

Hypofractionated Radiation

Download Full-text

A Biopsy Based Genomic Classifier Predicts Biochemical Failure and Metastasis after Definitive Radiation without Hormone Therapy in a Prospective Cohort of Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.06.254 ◽

2018 ◽

Vol 102 (3) ◽

pp. S99

Author(s):

M.L.K. Chua ◽

R.G. Bristow ◽

J. Murgic ◽

A. Hosni Abdalaty ◽

A. Salcedo ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Prospective Cohort ◽

Biochemical Failure ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Patterns of Daily Practice of Hormone Therapy in Unfavorable and Favorable Intermediate-Risk Prostate Cancer: Results of the French PROACT Survey

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1113 ◽

2017 ◽

Vol 99 (2) ◽

pp. E213

Author(s):

Y. Belkacemi ◽

I. Latorzef ◽

A. Hasbini ◽

D. Pasquier ◽

A. Toledano ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Daily Practice ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Refining Intermediate Risk Prostate Cancer: An Analysis of Prostate Biopsy Pathology and Implications for Hormone Therapy With Dose Escalated Radiation

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.1028 ◽

2012 ◽

Vol 84 (3) ◽

pp. S390

Author(s):

M.C. Ranck ◽

S. Liauw

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Prostate Biopsy ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

97 UPDATED RESULTS AND QUALITY OF LIFE ANALYSIS OF COMBINED HYPO-FRACTIONATED RADIATION AND HORMONE THERAPY FOR INTERMEDIATE RISK PROSTATE CANCER

Radiotherapy and Oncology ◽

10.1016/s0167-8140(12)72484-2 ◽

2009 ◽

Vol 92 ◽

pp. S31

Author(s):

A. Roux ◽

M. Yassa ◽

C. Lambert ◽

B. Fortin ◽

M. Audet-Lapointe ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Hormone Therapy ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Life Analysis ◽

Fractionated Radiation

Download Full-text

260: High Intensity Focused Ultrasound Combined with Endocrine Therapy in Treating High or Intermediate Risk Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)32527-8 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 86-86

Author(s):

Makoto Sumitomo ◽

Junichi Asakuma ◽

Yasumasa Hanawa ◽

Kazuhiko Nagakura ◽

Masamichi Hayakawa

Keyword(s):

Prostate Cancer ◽

Endocrine Therapy ◽

High Intensity ◽

Focused Ultrasound ◽

High Intensity Focused Ultrasound ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Low-dose rate brachytherapy for patients with low or intermediate-risk prostate cancer. Analysis of relapse-free survival

Experimental and Сlinical Urology ◽

10.29188/2222-8543-2019-11-2-44-49 ◽

2019 ◽

Vol 11 (2) ◽

pp. 44-49

Author(s):

V.A. Solodky ◽

◽

A.Yu. Pavlov ◽

A.D. Tsybulskiy ◽

A.S. Pchelintsev ◽

...

Keyword(s):

Prostate Cancer ◽

Dose Rate ◽

Low Dose ◽

Intermediate Risk ◽

Relapse Free Survival ◽

Free Survival ◽

Low Dose Rate ◽

Risk Prostate Cancer ◽

Low Dose Rate Brachytherapy

Download Full-text